Which has grown faster, COR or MRNA?

Over the past five years, MRNA grew revenue faster — COR at a 10.25% CAGR versus MRNA at 19.33%.

Does COR or MRNA pay a bigger dividend?

COR pays a dividend (0.74% yield), while MRNA has no payments in the available dividend history.

Is COR or MRNA more profitable?

COR runs the higher net margin — COR at 0.79% versus MRNA at -141.43%.

How have COR and MRNA total returns compared?

Over the past 5 years, COR delivered 15.54% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Cencora, Inc. (COR) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Cencora, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

COR

Cencora, Inc.

$61.70B

$317.10HealthcareAt close: Aug 19, 2026, 4:00 PM ET

MRNA

Moderna, Inc.

$69.19B

$174.38HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — COR vs MRNA

growth of $100 · dividends reinvested · last 8y

COR +288.7% (+18.5%/yr)MRNA +837.5% (+32.3%/yr)MRNA compounded faster over this window

COR MRNA

COR vs MRNA: by the numbers

•MRNA is the larger company ($69.19B vs $61.70B market cap).
•COR is profitable (0.79% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 10.25% CAGR).
•COR pays a dividend (0.74% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	COR	MRNA
P/E ratio	23.56	N/A
Forward P/E	17.79	N/A
P/S ratio	0.18	30.99
P/B ratio	20.16	10.21
EV / EBITDA	13.07	N/A
FCF yield	6.60%	N/A

Profitability

Metric	COR	MRNA
Gross margin	3.71%	55.35%
Operating margin	1.30%	-158.13%
Net margin	0.79%	-141.43%
ROE	86.03%	-46.61%
ROIC	12.75%	-39.16%

Dividends

Metric	COR	MRNA
Dividend yield	0.74%	N/A
Payout ratio	29.30%	N/A

Growth (annualized)

Metric	COR	MRNA
Revenue CAGR (5Y)	10.25%	19.33%
EPS CAGR (5Y)	11.97%	N/A
FCF CAGR (5Y)	9.63%	N/A
Total return CAGR (5Y)	22.82%	-14.22%

Frequently asked

Which has grown faster, COR or MRNA?: Over the past five years, MRNA grew revenue faster — COR at a 10.25% CAGR versus MRNA at 19.33%.
Does COR or MRNA pay a bigger dividend?: COR pays a dividend (0.74% yield), while MRNA has no payments in the available dividend history.
Is COR or MRNA more profitable?: COR runs the higher net margin — COR at 0.79% versus MRNA at -141.43%.
How have COR and MRNA total returns compared?: Over the past 5 years, COR delivered 15.54% and MRNA delivered -14.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COR analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Cencora P/E ratio Cencora dividend yield Cencora ROE Moderna ROE Cencora operating margin Moderna operating margin Cencora revenue growth Moderna revenue growth Cencora free cash flow Moderna free cash flow

Cencora & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.